Micro Interventional Devices, Inc.™ (MID) announced the second successful implantation of its MIA (Minimally Invasive Annuloplasty) technology. The patient was enrolled in the first arm of the STTAR (Study of Transcatheter Tricuspid Annular Repair) clinical trial studying the safety and efficacy of MID’s MIA device designed to eliminate or greatly reduce tricuspid regurgitation. More: http://prn.to/2gGlTae
Client & Alumni News
Micro Interventional Devices Continues Clinical Success
The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.